In addition, cannabinoids, a newly emerging therapy in treatment of refractory epilepsy, can indirectly modulate glutaminergic neurotransmission through neuronal cannabinoid receptor 1 (CB1).51 This evidence concerns the gene CNR1 and epilepsy.